To confirm the effect of TIMP-1 on CAFs, we performed similar IHC analyses on the tumor sections derived from the in vivo studies of HCT116 colon cancers with or without increased expression of TIMP-1. Here, TIMP1 is linked to malignant colon neoplasm.